American National Insurance’s Edwards Lifesciences EW Stock Holding History

American National Insurance’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,880	Closed	-$326K	–	284
2021 Q3	$326K	Hold	2,880	–	–	0.01%	326
2021 Q2	$298K	Hold	2,880	–	–	0.01%	336
2021 Q1	$241K	Hold	2,880	–	–	0.01%	338
2020 Q4	$263K	Hold	2,880	–	–	0.01%	326
2020 Q3	$230K	Buy	+2,880	New	+$225K	0.01%	309
2020 Q1	–	Sell	-2,880	Closed	-$224K	–	326
2019 Q4	$224K	Hold	2,880	–	–	0.01%	315
2019 Q3	$211K	Buy	+2,880	New	+$202K	0.01%	315
2013 Q3	–	Sell	-23,352	Closed	-$262K	–	343
2013 Q2	$262K	Buy	+23,352	New	+$276K	0.02%	317

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American National Insurance's EW Position: Q4 2021 in Review

American National Insurance sold out of Edwards Lifesciences (EW) in Q4 2021, closing a stake of 2,880 shares — an estimated $326K sold.

American National Insurance first reported a position in EW in Q2 2013 and held it in 8 quarters. The position peaked at $326K in Q3 2021. 1,320 funds tracked by Wall St. Rank hold EW as of Q4 2021.

American National Insurance reported no remaining Edwards Lifesciences position as of Q4 2021 after selling out during the quarter.
American National Insurance sold 2,880 Edwards Lifesciences shares in Q4 2021, an estimated $326K.
American National Insurance first reported a position in Edwards Lifesciences in Q2 2013 and held it in 8 quarters.
American National Insurance's Edwards Lifesciences position peaked at $326K in Q3 2021.
1,320 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2021.

Based on American National Insurance's 13F filing for Q4 2021, filed 9 Feb 2022.